Pfizer, Accenture, UPS & Amcor: This Week in Healthcare

Dave Denton Steps Down as Pfizer's Chief Financial Officer

Pfizer has confirmed that Dave Denton, Executive Vice President and Chief Financial Officer, will leave the company on 15 August. He is moving to a new role in the consumer goods sector.

Cecile Guegan, Senior Vice President of Finance for the global biopharmaceutical business, will assume the Chief Financial Officer position on an interim basis from 16 August. The company is conducting an internal and external search for a permanent appointment.

Dave and Cecile will work together during the handover period to maintain continuity.

Accenture: Acquiring Alfahealth to Enhance AI in Healthcare

Healthcare organisations across Italy and Europe are adopting AI to address fragmented data systems and improve care delivery. The technology could enable more integrated clinical workflows and support decision making across hospitals and community providers.

As healthcare systems face mounting pressure from ageing populations and resource constraints, the integration of AI-driven technologies represents a strategic response to operational challenges. Digital transformation initiatives are becoming central to how healthcare organisations plan for future demand while maintaining quality standards.

Accenture has agreed to acquire Alfahealth, a digital health platform company with operations across Italy's healthcare sector. The transaction could expand Accenture's presence in healthcare AI and data integration services.

Sustainable Beauty: Consumers Push for Refillable Packaging

Amcor has released consumer research examining refill packaging within the personal care sector. The packaging solutions provider surveyed 2,749 consumers across six European countries to understand attitudes towards refillable formats for beauty and hygiene products.

According to Amcor, refill packaging has become established across multiple personal care categories. These include haircare, liquid soap and bath products.

The research examined how consumers interact with refillable systems. It also explored what factors could determine future adoption rates.

Sanofi & Pangaea's Clinical AI-Powered AATD Detections

AI continues to play an increasingly important role in transforming healthcare delivery, particularly in the identification of patients with underdiagnosed conditions. 

Pangaea Data, a provider of guideline-configured AI solutions, is collaborating with Sanofi to improve the detection of Alpha-1 Antitrypsin Deficiency (AATD) across the US. 

The initiative aims to deploy Pangaea's AI platform within large health systems and low-resource community care settings to help identify patients who may require further evaluation. 

By leveraging existing electronic health record (EHR) data, the collaboration aims to reduce diagnostic delays and improve access to timely care for individuals living with this rare genetic condition.

UPS: Investing US$48m for Cold Prescription Deliveries

Temperature control failures in pharmaceutical distribution carry an estimated annual cost of up to US$35bn.

For healthcare organisations moving critical treatments from manufacturers to patients, this makes reliable cold chain infrastructure a necessity rather than an option.

UPS has committed US$48m to expand its temperature-controlled freight cross-dock facilities across 27 locations in Europe, Asia and the Americas.

The investment targets the company's ability to manage products requiring strict thermal parameters between manufacturers and healthcare providers.